Clinical Trials Directory

Trials / Conditions / Non-Muscle Invasive Bladder Neoplasms

Non-Muscle Invasive Bladder Neoplasms

10 registered clinical trials studyying Non-Muscle Invasive Bladder Neoplasms — 7 currently recruiting.

StatusTrialSponsorPhase
RecruitingA Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Can
NCT07309445
Janssen Research & Development, LLC—
RecruitingA Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Musc
NCT06919965
Janssen Research & Development, LLCPhase 3
RecruitingA Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
NCT06833073
Merck Sharp & Dohme LLCPhase 2
RecruitingA Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Can
NCT06319820
Janssen Research & Development, LLCPhase 3
Active Not RecruitingA Study of TAR-200 Versus Intravesical Chemotherapy in Participants With Recurrent High-Risk Non-Muscle-Invasi
NCT06211764
Janssen Research & Development, LLCPhase 3
RecruitingA Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer
NCT05483868
Aura BiosciencesPhase 1
RecruitingStudy of Erdafitinib Intravesical Delivery System for Localized Bladder Cancer
NCT05316155
Janssen Research & Development, LLCPhase 1 / Phase 2
Active Not RecruitingBladMetrix Urine Test for Monitoring Recurrence in Non-Muscle Invasive Bladder Cancer
NCT07511517
Oslo University Hospital—
RecruitingStudy on the Occurrence of Possible Relapses and on the Quality of Life in Patients Who Underwent TURBK.
NCT06167356
IRCCS San Raffaele—
Approved For MarketingPre-Approval Expanded Access Study for TAR-200 Treating Physician Use
NCT06877676
Janssen Research & Development, LLC—